Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-25 @ 9:53 PM
Study NCT ID:
NCT04959851
Status:
COMPLETED
Last Update Posted:
2024-08-06
First Post:
2021-07-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-18
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-02
First Submit QC Date:
None
Study First Post Date:
2021-07-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-05
Last Update Post Date:
2024-08-06
Last Update Post Date Type:
ACTUAL